title: New ACR guidelines for gout management hold some surprises.
abstract: Despite exciting progress in the understanding and treatment of gout, management of this condition remains suboptimal. In the face of this inadequacy, new guidelines provide recommendations both for therapeutic approaches to hyperuricaemia and for the management and anti-inflammatory prophylaxis of acute gouty arthritis.
authors.affiliation: Rheumatology Department, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, 75475 Paris CEDEX 10, France. thomas.bardin@lrb.aphp.fr
authors.forename: Thomas
authors.initials: T
authors.lastname: Bardin
authors.forename: Pascal
authors.initials: P
authors.lastname: Richette
mesh_terms: D000208:Acute Disease; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D015210:Arthritis, Gouty / Q000097:blood / Q000188:drug therapy* / Q000517:prevention & control; D006074:Gout Suppressants / Q000627:therapeutic use*; D006801:Humans; D033461:Hyperuricemia / Q000097:blood / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D012219:Rheumatology / Q000379:methods*; D012955:Societies, Medical; D014481:United States
chemical_list: D000893:Anti-Inflammatory Agents; D006074:Gout Suppressants